Insider Transactions Reported by 21 Insiders of RxSight, Inc.

Symbol
RXST on Nasdaq
Location
Aliso Viejo, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

RxSight, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RxSight I, LLC 10%+ Owner $96,806,554 03 Aug 2021
Richard M. Wolfen Director $88,332,816 03 Aug 2021
Bruce C. Robertson Director $66,482,607 03 Aug 2021
Daniel Mark Schwartz Director $19,567,301 03 Aug 2021
RA CAPITAL MANAGEMENT, L.P. 10%+ Owner $10,265,312 03 Aug 2021
Eric Weinberg Exhibit 24 - Power of Attorney Chief Business Development Officer $4,697,521 27 Feb 2026
Jesse Anderson Corley Director $928,669 03 Jun 2025
William J. Link PhD Director $771,884 03 Jun 2025
Juliet Tammenoms Bakker Director $649,002 03 Jun 2025
PALMISANO ROBERT J Director $535,969 03 Jun 2025
Robert Keith Warner Director $535,969 03 Jun 2025
Julie Andrews Director $535,969 03 Jun 2025
Tamara Fountain Director $464,217 03 Jun 2025
Raymond W. Cohen Director $285,344 31 Jul 2025
Ilya Goldshleger Chief Operating Officer $283,856 27 Feb 2026
Shweta Maniar Director $236,843 03 Jun 2025
Shelley B. Thunen Co-President and Chief Financial Officer $166,403 14 Apr 2025
Scott Gaines Chief Customer Officer $112,993 27 Feb 2026
Mark Wilterding Chief Financial Officer $94,158 28 Feb 2026
Christopher Cox Director 29 Jul 2021
Ronald M. Kurtz MD President & CEO, Director 27 Feb 2026

Recent Insider Transactions by Companies or Individuals for RxSight, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Mark Wilterding RXST Common Stock Tax liability -39.5% -8,068 12,373 28 Feb 2026 Direct
Mark Wilterding RXST Common Stock Options Exercise 20,441 20,441 28 Feb 2026 Direct
Mark Wilterding RXST Restricted Stock Unit Options Exercise -12.5% -20,441 143,087 28 Feb 2026 Direct
Scott Gaines RXST Common Stock Tax liability -14.8% -2,580 14,848 28 Feb 2026 Direct
Scott Gaines RXST Common Stock Options Exercise 56.1% 6,261 17,428 28 Feb 2026 Direct
Scott Gaines RXST Restricted Stock Unit Options Exercise -72.2% -6,261 2,414 28 Feb 2026 Direct
Scott Gaines RXST Restricted Stock Unit Award 32,218 32,218 27 Feb 2026 Direct
Ilya Goldshleger RXST Restricted Stock Unit Award 32,218 32,218 27 Feb 2026 Direct
Eric Weinberg RXST Restricted Stock Unit Award 32,218 32,218 27 Feb 2026 Direct
Ronald M. Kurtz MD RXST Restricted Stock Unit Award 80,545 80,545 27 Feb 2026 Direct
Mark Wilterding RXST Restricted Stock Unit Award 163,528 163,528 12 Jan 2026 Direct
Mark Wilterding RXST Stock Option (right to buy) Award 258,770 258,770 12 Jan 2026 Direct
Ilya Goldshleger RXST Common Stock Options Exercise 55.5% 23,445 65,691 25 Sep 2025 Direct
Ilya Goldshleger RXST Stock Option (right to buy) Options Exercise -100% -23,445 0 25 Sep 2025 Direct
Raymond W. Cohen RXST Common Stock Award 35,668 35,668 31 Jul 2025 Direct
William J. Link PhD RXST Common Stock Award 39.7% 10,752 37,855 03 Jun 2025 Direct
Tamara Fountain RXST Common Stock Award 43.4% 10,752 35,545 03 Jun 2025 Direct
Robert Keith Warner RXST Common Stock Award 35.5% 10,752 41,039 03 Jun 2025 Direct
Shweta Maniar RXST Common Stock Award 145.6% 10,752 18,135 03 Jun 2025 Direct
Palmisano Robert J RXST Common Stock Award 35.5% 10,752 41,039 03 Jun 2025 Direct
Julie Andrews RXST Common Stock Award 35.5% 10,752 41,039 03 Jun 2025 Direct
Bakker Juliet Tammenoms RXST Common Stock Award 28.8% 10,752 48,146 03 Jun 2025 Direct
Jesse Anderson Corley RXST Common Stock Award 28% 10,752 49,190 03 Jun 2025 Direct
Eric Weinberg RXST Common Stock Options Exercise 2558.2% 188,002 195,351 02 Jun 2025 Direct
Eric Weinberg RXST Stock Option (right to buy) Options Exercise -100% -188,002 0 02 Jun 2025 Direct
Shelley B. Thunen RXST Common Stock Options Exercise 25.5% 7,792 38,354 14 Apr 2025 Direct
Shelley B. Thunen RXST Stock Option (right to buy) Options Exercise -100% -7,792 0 14 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.